No fees unless we win.
Get a free consultation
According to the Washington Post, physicians who wrote guidelines aimed at preventing heart attacks and strokes are having to defend against strong criticism that the guidelines overestimate the risk for certain groups of people. The formula would allegedly expand the number of people who would be considered for cholesterol-lowering drugs like Lipitor, Zocor or their generic forms.
The doctors who drafted the advice for the American Heart Association and the American College of Cardiology claim that any flaws in their formula are small. However, in an opinion piece in the British journal Lancet, Paul Ridker and Nancy Cook, physicians at Brigham and Women’s Hospital in Boston, describe how they tried the formula on patients in three large, observational clinical trials and found that it was way off in terms of the number of heart attacks and strokes those patients actually had.
Under the new guidelines, one-third of U.S. adults ages 40 to 75 would meet the standards to take a statin. “Under the current guidelines, statins are recommended for only about 15 percent of this group,” the Post reported.
“The predicted risk is roughly twice as high as the observed risk,” Paul Ridker said, according to the Post.
Drugs like Lipitor work by preventing an enzyme in the liver from creating low-density lipids. However, the drug has been linked to Type 2 diabetes in women. Despite this issue, Lipitor manufacturer Pfizer continues to aggressively market and sell the product.
Our defective drug attorneys at the law firm of Zoll, Kranz & Borgess, LLC represent women who have developed type 2 diabetes from Lipitor use. For more information, contact our experienced pharmaceutical drug and device attorneys by calling toll-free (888) 841-9623
today.
Zoll, Kranz & Borgess, LLC – Multidistrict Litigation Attorneys
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
